Upgrade to SI Premium - Free Trial

UBS Reiterates Neutral Rating on Clorox (CLX) Following Meeting With Management

September 11, 2026 9:15 AM
UBS analyst Peter Grom reiterated a Neutral rating and $105.00 price target on Clorox (NYSE: CLX).The analyst commented, "We attended ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments